Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies ; volume:12 ; number:1 ; year:2019 ; pages:304-310
Case reports in oncology ; 12, Heft 1 (2019), 304-310
- Creator
-
Mitani, Seiichiro
Kadowaki, Shigenori
Kato, Kyoko
Masuishi, Toshiki
Muro, Kei
- DOI
-
10.1159/000499705
- URN
-
urn:nbn:de:101:1-2019051600465373188513
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mitani, Seiichiro
- Kadowaki, Shigenori
- Kato, Kyoko
- Masuishi, Toshiki
- Muro, Kei
Other Objects (12)
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer
Refractory benign esophageal strictures
Endoscopic incision plus esophageal stenting for refractory esophageal stricture in children
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial
An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report
Endoscopic stricturotomy for a refractory complex esophageal stricture
DNA-Schädigung durch Cisplatin und Oxaliplatin im Thymidylatsynthasegen bei 5-Fluorouracil-resistenten und -sensiblen L1210-Zellen
Phenoxodiol sensitizes metastatic colorectal cancer cells to 5-fluorouracil- and oxaliplatin-induced apoptosis through intrinsic pathway
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205
Polyglycolic acid sheets for repair of refractory esophageal fistula
Refractory strictures despite steroid injection after esophageal endoscopic resection
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer
Refractory benign esophageal strictures
Endoscopic incision plus esophageal stenting for refractory esophageal stricture in children
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial
An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report
Endoscopic stricturotomy for a refractory complex esophageal stricture
DNA-Schädigung durch Cisplatin und Oxaliplatin im Thymidylatsynthasegen bei 5-Fluorouracil-resistenten und -sensiblen L1210-Zellen
Phenoxodiol sensitizes metastatic colorectal cancer cells to 5-fluorouracil- and oxaliplatin-induced apoptosis through intrinsic pathway
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205
Polyglycolic acid sheets for repair of refractory esophageal fistula
Refractory strictures despite steroid injection after esophageal endoscopic resection
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer
Refractory benign esophageal strictures
Endoscopic incision plus esophageal stenting for refractory esophageal stricture in children
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial
An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report
Endoscopic stricturotomy for a refractory complex esophageal stricture
DNA-Schädigung durch Cisplatin und Oxaliplatin im Thymidylatsynthasegen bei 5-Fluorouracil-resistenten und -sensiblen L1210-Zellen
Phenoxodiol sensitizes metastatic colorectal cancer cells to 5-fluorouracil- and oxaliplatin-induced apoptosis through intrinsic pathway
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205
Polyglycolic acid sheets for repair of refractory esophageal fistula